Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05640895 · ClinicalTrials.gov registry record

Intravitreal Injection Site and Perceived Pain

A clinical trial of Pain, sponsored by The University of Texas Medical Branch, Galveston.

Completed
Registry status
53
Enrollment target
1
Study location

NCT05640895 is a study of Pain that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 53 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05640895, a study of Pain, has completed, sponsored by The University of Texas Medical Branch, Galveston.

COMPLETED
Registry status
53 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to explore the perception of pain during intravitreal injection related to the distance of the entry site from the limbus.

Conditions Studied

Interventions

  • PROCEDURE Intravitreal injection site

Study Locations (1)

Texas

  • University of Texas Medical Branch - Galveston

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2022-11-14
Est. Completion 2024-09-09

What the Registry Record Tells You About NCT05640895

The ClinicalTrials.gov registry entry for NCT05640895 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (83% lower). The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Intravitreal injection site is the first listed.

NCT05640895 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05640895 about?

NCT05640895 is a clinical study titled "Intravitreal Injection Site and Perceived Pain". The objective of this study is to explore the perception of pain during intravitreal injection related to the distance of the entry site from the limbus.

What is the current status of trial NCT05640895?

This trial is currently completed. The enrollment target is 53 participants. The study started on 2022-11-14. Estimated completion is 2024-09-09.

What conditions does trial NCT05640895 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT05640895?

The interventions under investigation include: Intravitreal injection site (PROCEDURE).

Who is sponsoring clinical trial NCT05640895?

This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05640895 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.